価格表

在庫・価格 : 2024年06月20日 02時40分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-GLP1R, Rabbit-Poly
データシート
NBP1-97308 NOVノバス バイオロジカルス
Novus biologicals, LLC
0.1 ml ¥91,000
(未発注)
追加

在庫・価格 : 2024年06月20日 02時40分 現在

Anti-GLP1R, Rabbit-Poly

  • 商品コード:NBP1-97308
  • メーカー:NOV
  • 包装:0.1ml
  • 価格: ¥91,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Kedees MH et al. Functional activity of murine intestinal mucosal cells is regulated by the glucagon-like peptide-1 receptor. Peptides 2013 Oct;48:36-44
Kedees MH et al
2013/01/01
PubMed
2 Steven S et al. Glucagon-like peptide-1 receptor signalling reduces microvascular thrombosis, nitro-oxidative stress and platelet activation in endotoxaemic mice. Br. J. Pharmacol. 2016 Jul;
Steven S et al
2016/01/01
PubMed
3 Ihara M et al. An interaction between glucagon-like peptide-1 and adenosine contributes to cardioprotection of a dipeptidyl peptidase 4 inhibitor from myocardial ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 2015 May;308(10):H1287-97
Ihara M et al
2015/01/01
PubMed
4 Tsutsumi Y et al. Combined Treatment with Exendin-4 and Metformin Attenuates Prostate Cancer Growth. PLoS ONE 2015;10(10):e0139709
Tsutsumi Y et al
2015/01/01
PubMed
5 Iwaya C et al. Exendin-4, a Glucagonlike Peptide-1 Receptor Agonist, Attenuates Breast Cancer Growth by Inhibiting NF-κB Activation. Endocrinology 2017 12;158(12):4218-4232
Iwaya C et al
2017/01/01
Species: Human, Applications: IHC-P PubMed
6 Wenjing H et al. Exendin-4 does not modify growth or apoptosis of human colon cancer cells. Endocr. Res. 2017 Aug;42(3):209-218
Wenjing H et al
2017/01/01
Species: Human, Applications: IHC PubMed
7 He W et al. Exendin-4 inhibits growth and augments apoptosis of ovarian cancer cells. Mol. Cell. Endocrinol. 2016 11;436:240-9
He W et al
2016/01/01
Species: Human, Applications: IHC PubMed
8 Chaudhari S et al. Inhibition of interleukin-6 on matrix protein production by glomerular mesangial cells and the pathway involved. Am J Physiol Renal Physiol 2020 06;318(6):F1478-F1488
Chaudhari S et al
2020/01/01
PubMed
9 Yang X et al. Mesenchymal stem cells combined with liraglutide relieve acute lung injury through apoptotic signaling restrained by PKA/β-catenin. Stem Cell Res Ther 2020 05;11(1):182
Yang X et al
2020/01/01
PubMed
10 Timper K et al. GLP-1 Receptor Signaling in Astrocytes Regulates Fatty Acid Oxidation, Mitochondrial Integrity, and Function. Cell Metab 2020 06;31(6):1189-1205.e13
Timper K et al
2020/01/01
PubMed
11 Feng Y et al. Effect of hCMSCs and liraglutide combination in ALI through cAMP/PKAc/β-catenin signaling pathway. Stem Cell Res Ther 2020 01;11(1):2
Feng Y et al
2020/01/01
PubMed
12 Deng H et al. Long-Term Liraglutide Administration Induces Pancreas Neogenesis in Adult T2DM Mice. Cell Transplant ;29:963689720927392
Deng H et al
PubMed
13 Nomiyama T et al. GLP-1 receptor agonist as treatment for cancer as well as diabetes: beyond blood glucose control. Expert Rev Endocrinol Metab 2016 Jul;11(4):357-364
Nomiyama T et al
2016/01/01
PubMed
14 Sho H et al. Insulinoma induces a hyperinsulinemia-mediated decrease of GLUT2 and GLP1 receptor in normal pancreatic β-cells. Biochem Biophys Res Commun 2021 01;534:702-706
Sho H et al
2021/01/01
PubMed
15 Nomiyama T et al. Exendin-4, a GLP-1 receptor agonist, attenuates prostate cancer growth. Diabetes 2014 Nov;63(11):3891-905
Nomiyama T et al
2014/01/01
PubMed
16 Li Y et al. Liraglutide protects against lethal renal ischemia-reperfusion injury by inhibiting high-mobility group box 1 nuclear-cytoplasmic translocation and release. Pharmacol Res 2021 11;173:105867
Li Y et al
2021/01/01
Species: Mouse, Applications: IHC, WB PubMed
17 Mieczkowska A et al. [Gly²]-GLP-2, But Not Glucagon or [D-Ala²]-GLP-1, Controls Collagen Crosslinking in Murine Osteoblast Cultures. Front Endocrinol (Lausanne) 2021;12:721506
Mieczkowska A et al
2021/01/01
Applications: WB PubMed
  • No.: 1
  • 文献情報:
    Kedees MH et al. Functional activity of murine intestinal mucosal cells is regulated by the glucagon-like peptide-1 receptor. Peptides 2013 Oct;48:36-44
    Kedees MH et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Steven S et al. Glucagon-like peptide-1 receptor signalling reduces microvascular thrombosis, nitro-oxidative stress and platelet activation in endotoxaemic mice. Br. J. Pharmacol. 2016 Jul;
    Steven S et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Ihara M et al. An interaction between glucagon-like peptide-1 and adenosine contributes to cardioprotection of a dipeptidyl peptidase 4 inhibitor from myocardial ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 2015 May;308(10):H1287-97
    Ihara M et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Tsutsumi Y et al. Combined Treatment with Exendin-4 and Metformin Attenuates Prostate Cancer Growth. PLoS ONE 2015;10(10):e0139709
    Tsutsumi Y et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Iwaya C et al. Exendin-4, a Glucagonlike Peptide-1 Receptor Agonist, Attenuates Breast Cancer Growth by Inhibiting NF-κB Activation. Endocrinology 2017 12;158(12):4218-4232
    Iwaya C et al
    2017/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Wenjing H et al. Exendin-4 does not modify growth or apoptosis of human colon cancer cells. Endocr. Res. 2017 Aug;42(3):209-218
    Wenjing H et al
    2017/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    He W et al. Exendin-4 inhibits growth and augments apoptosis of ovarian cancer cells. Mol. Cell. Endocrinol. 2016 11;436:240-9
    He W et al
    2016/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Chaudhari S et al. Inhibition of interleukin-6 on matrix protein production by glomerular mesangial cells and the pathway involved. Am J Physiol Renal Physiol 2020 06;318(6):F1478-F1488
    Chaudhari S et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Yang X et al. Mesenchymal stem cells combined with liraglutide relieve acute lung injury through apoptotic signaling restrained by PKA/β-catenin. Stem Cell Res Ther 2020 05;11(1):182
    Yang X et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Timper K et al. GLP-1 Receptor Signaling in Astrocytes Regulates Fatty Acid Oxidation, Mitochondrial Integrity, and Function. Cell Metab 2020 06;31(6):1189-1205.e13
    Timper K et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Feng Y et al. Effect of hCMSCs and liraglutide combination in ALI through cAMP/PKAc/β-catenin signaling pathway. Stem Cell Res Ther 2020 01;11(1):2
    Feng Y et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Deng H et al. Long-Term Liraglutide Administration Induces Pancreas Neogenesis in Adult T2DM Mice. Cell Transplant ;29:963689720927392
    Deng H et al
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Nomiyama T et al. GLP-1 receptor agonist as treatment for cancer as well as diabetes: beyond blood glucose control. Expert Rev Endocrinol Metab 2016 Jul;11(4):357-364
    Nomiyama T et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Sho H et al. Insulinoma induces a hyperinsulinemia-mediated decrease of GLUT2 and GLP1 receptor in normal pancreatic β-cells. Biochem Biophys Res Commun 2021 01;534:702-706
    Sho H et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Nomiyama T et al. Exendin-4, a GLP-1 receptor agonist, attenuates prostate cancer growth. Diabetes 2014 Nov;63(11):3891-905
    Nomiyama T et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Li Y et al. Liraglutide protects against lethal renal ischemia-reperfusion injury by inhibiting high-mobility group box 1 nuclear-cytoplasmic translocation and release. Pharmacol Res 2021 11;173:105867
    Li Y et al
    2021/01/01
  • 備考:
    Species: Mouse, Applications: IHC, WB
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Mieczkowska A et al. [Gly²]-GLP-2, But Not Glucagon or [D-Ala²]-GLP-1, Controls Collagen Crosslinking in Murine Osteoblast Cultures. Front Endocrinol (Lausanne) 2021;12:721506
    Mieczkowska A et al
    2021/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed